Literature DB >> 1446082

Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study.

B Cribier1, G Prévost, P Couppie, V Finck-Barbançon, E Grosshans, Y Piémont.   

Abstract

Panton-Valentine leukocidin (PVL) is a Staphylococcus aureus (SA) exotoxin, which kills human granulocytes and monocytes in vitro. Among 43 SA strains from cutaneous infections, 12 were PVL producers, whereas among 49 blood culture strains, only 1 produced PVL. Most PVL-producing strains (11/22) came from 22 primitive cutaneous infections, especially furuncles and abscesses, while only 1 PVL-producing strain came from 21 secondary infections of dermatoses such as bullous or pruritic diseases. Intradermal injections of PVL in rabbits induced edema, erythema and necrosis; histopathological changes at the injection sites consisted mainly in leukocytoclasis and vascular necrosis. All changes were dose dependent, and previous immunization of rabbits partially neutralized PVL-induced effects. Production of PVL in vivo after injections of bacteria seems to be low, and the histopathological lesions induced in the rabbit skin do not appear to be specifically related to PVL activity. However, PVL is a good candidate as a new virulence factor in cutaneous SA infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446082     DOI: 10.1159/000247443

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  53 in total

1.  Breast milk transmission of a Panton-Valentine leukocidin-producing Staphylococcus aureus strain causing infantile pneumonia.

Authors:  I Le Thomas ; P Mariani-Kurkdjian; A Collignon; A Gravet; O Clermont; N Brahimi; J Gaudelus; Y Aujard; J Navarro; F Beaufils; E Bingen
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors.

Authors:  Jose M. Eguia; Henry F. Chambers
Journal:  Curr Infect Dis Rep       Date:  2003-12       Impact factor: 3.725

Review 3.  Virulence strategies of the dominant USA300 lineage of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA).

Authors:  Lance R Thurlow; Gauri S Joshi; Anthony R Richardson
Journal:  FEMS Immunol Med Microbiol       Date:  2012-03-05

4.  Relative contribution of Panton-Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatants.

Authors:  Shawna F Graves; Scott D Kobayashi; Kevin R Braughton; Binh An Diep; Henry F Chambers; Michael Otto; Frank R Deleo
Journal:  Microbes Infect       Date:  2010-02-19       Impact factor: 2.700

5.  Emergence of virulent methicillin-resistant Staphylococcus aureus strains carrying Panton-Valentine leucocidin genes in The Netherlands.

Authors:  W J B Wannet; E Spalburg; M E O C Heck; G N Pluister; E Tiemersma; R J L Willems; X W Huijsdens; A J de Neeling; J Etienne
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 6.  Community-associated methicillin-resistant Staphylococcus aureus and its emerging virulence.

Authors:  Sanjay K Shukla
Journal:  Clin Med Res       Date:  2005-05

7.  Panton-Valentine leukocidin genes in a laboratory quality control strain of Staphylococcus aureus.

Authors:  W Michael Dunne
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

Review 8.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

Review 9.  Skin microbiota: a source of disease or defence?

Authors:  A L Cogen; V Nizet; R L Gallo
Journal:  Br J Dermatol       Date:  2008-03       Impact factor: 9.302

10.  GTP-binding proteins are involved in the modulated activity of human neutrophils treated with the Panton-Valentine leukocidin from Staphylococcus aureus.

Authors:  T Hensler; M Köller; G Prévost; Y Piémont; W König
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.